Was This Lorazepam Dosing Safe?
While you tolerated the 2.5 mg total dose without apparent immediate harm, this dosing pattern exceeded standard recommendations and carried significant risks—particularly for respiratory depression during the scan itself. The fact that you tolerated it does not make it safe practice, and this approach should not be repeated.
Why This Dosing Was Problematic
Exceeded Standard Preanesthetic Dosing
The FDA-approved dosing for lorazepam as a preanesthetic sedative is 0.05 mg/kg up to a maximum of 4 mg 1. At 135 lbs (approximately 61 kg), your calculated maximum would be about 3 mg. However, the standard recommended initial IV dose is 2 mg total, or 0.02 mg/lb (0.044 mg/kg), whichever is smaller 1. Your 2.5 mg total dose falls between these ranges but was given in a stacked fashion over a short period.
Timing and Accumulation Issues
You administered:
- 1 mg at 2 hours before
- 1 mg at 1 hour before
- 0.5 mg immediately before
This creates problematic pharmacokinetic overlap. Lorazepam reaches peak plasma concentration at approximately 2 hours after oral administration 2, with an elimination half-life of 12-14 hours 1, 2. Your first 1 mg dose was still reaching peak levels when you added the second dose, and both were at or near peak when you added the third dose. This stacking effect means you likely achieved higher peak plasma concentrations than intended.
Respiratory Depression Risk During Scanning
The most critical safety concern is respiratory depression, especially in the supine position required for MRI scanning 1. The FDA label explicitly warns: "AIRWAY OBSTRUCTION MAY OCCUR IN HEAVILY SEDATED PATIENTS. INTRAVENOUS LORAZEPAM AT ANY DOSE, WHEN GIVEN EITHER ALONE OR IN COMBINATION WITH OTHER DRUGS...MAY PRODUCE HEAVY SEDATION; THEREFORE, EQUIPMENT NECESSARY TO MAINTAIN A PATENT AIRWAY AND TO SUPPORT RESPIRATION/VENTILATION SHOULD BE AVAILABLE" 1.
During a 2-hour scan in an MRI tube, you were:
- Lying supine (increases airway obstruction risk)
- Potentially unable to communicate distress
- In an environment where emergency airway intervention would be delayed
- Without respiratory monitoring equipment
What the Evidence Shows About Safety
Sedation and Cognitive Effects
At 4 mg oral lorazepam (higher than your dose but relevant), studies show marked sedation with postoperative residual effects on attention, cognitive, somatic and visceral functions present until 5 hours post-medication 3. The study concluded lorazepam "is not recommended for outpatient anesthesia because it prolongs recovery" 3.
Individual Variability
A recent 2025 case report documented a 30-year-old male who developed dose-related orthostatic symptoms with lorazepam, with symptoms reliably worse on 2 mg nights 4. This highlights significant individual variability in response, even in young healthy adults.
Proper Timing for Amnesia
For optimal amnestic effect (lack of recall), intramuscular lorazepam should be administered at least 2 hours before the procedure, and IV lorazepam 15-20 minutes before 1. Your oral dosing pattern doesn't align with evidence-based timing for either route.
Common Pitfalls to Avoid
Don't assume tolerance means safety: Just because you didn't experience obvious adverse effects doesn't mean the dosing was appropriate. Respiratory depression can be subtle and progressive.
Don't self-escalate based on scan duration: The 0.5 mg addition "because this was longer" reflects a misunderstanding—sedation depth, not duration, determines dosing needs.
Don't stack doses without medical supervision: The pharmacokinetics of lorazepam make dose stacking particularly risky due to the long half-life and delayed peak effects.
What Should Have Been Done
The appropriate approach would have been:
- Single dose of 2 mg lorazepam taken 2 hours before the scan 1
- Medical supervision during the scan with pulse oximetry monitoring
- Clear communication with the radiology team about sedation
- Arrangement for someone to drive you home (no driving for 24-48 hours post-dose) 1
For future scans requiring more sedation:
- Discuss with your physician about supervised procedural sedation
- Consider alternative anxiolytics with shorter half-lives
- Ensure proper monitoring equipment and trained personnel are present
Bottom Line
While you emerged without apparent harm, this dosing pattern placed you at unnecessary risk for respiratory depression in an unmonitored environment. The 2.5 mg total dose via stacked oral administration over 2 hours, followed by a 2-hour scan in a confined space without medical monitoring, violated multiple safety principles outlined in FDA labeling 1. Do not repeat this approach—consult your physician for proper procedural sedation planning for future imaging studies.